Rett syndrome (RTT) is a rare neurodevelopmental disorder primarily affecting females, caused by mutations in the MECP2 gene (Methyl-CpG Binding Protein 2). While classically considered a developmental disorder, RTT shares significant overlap with neurodegenerative conditions, including features of neuronal dysfunction, synaptic impairment, and progressive motor deficits. Understanding the neuronal alterations in RTT provides crucial insights into mechanisms of synaptic plasticity, chromatin regulation, and neuronal survival that are relevant to neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and Huntington's disease.
Introduction
Rett syndrome is one of the most common causes of intellectual disability in females, affecting approximately 1 in 10,000-15,000 live female births[@rett2020]. The disorder is caused by loss-of-function mutations in the MECP2 gene, which encodes a methyl-DNA binding protein critical for transcriptional regulation of thousands of genes in neurons[@mecp2020]. Although RTT is classified as a neurodevelopmental disorder, research has revealed significant parallels with neurodegenerative processes, including:
Rett syndrome (RTT) is a rare neurodevelopmental disorder primarily affecting females, caused by mutations in the MECP2 gene (Methyl-CpG Binding Protein 2). While classically considered a developmental disorder, RTT shares significant overlap with neurodegenerative conditions, including features of neuronal dysfunction, synaptic impairment, and progressive motor deficits. Understanding the neuronal alterations in RTT provides crucial insights into mechanisms of synaptic plasticity, chromatin regulation, and neuronal survival that are relevant to neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and Huntington's disease.
Introduction
Rett syndrome is one of the most common causes of intellectual disability in females, affecting approximately 1 in 10,000-15,000 live female births[@rett2020]. The disorder is caused by loss-of-function mutations in the MECP2 gene, which encodes a methyl-DNA binding protein critical for transcriptional regulation of thousands of genes in neurons[@mecp2020]. Although RTT is classified as a neurodevelopmental disorder, research has revealed significant parallels with neurodegenerative processes, including:
These shared mechanisms make RTT neurons an important model for understanding neurodegeneration.
Molecular Genetics
MECP2 Gene and Protein
The MECP2 gene located on chromosome Xq28 encodes Methyl-CpG Binding Protein 2 (MeCP2), a transcriptional regulator that binds to methylated DNA and recruits chromatin-remodeling complexes[@methylcpg]. Key features include:
Rett syndrome neurons provide a critical model for understanding the intersection of neurodevelopmental and neurodegenerative processes. The shared mechanisms between RTT and major neurodegenerative diseases—including transcriptional dysregulation, synaptic impairment, mitochondrial dysfunction, and neuroinflammation—highlight the importance of MECP2 biology in neuronal health and survival. Advances in gene therapy and small molecule approaches offer hope for disease-modifying treatments that may benefit not only RTT patients but also those with related neurodegenerative conditions.
Background
The study of Rett Syndrome Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[International Rett Syndrome Foundation](https://www.rettsyndrome.org/) - Patient advocacy and research
[PubMed - Rett Syndrome](https://pubmed.ncbi.nlm.nih.gov/?term=rett+syndrome+neurons) - Literature database
[GeneReviews - Rett Syndrome](https://www.ncbi.nlm.nih.gov/books/NBK99997/) - Clinical information